Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of flavopiridol in treating patients who have recurrent or metastatic head and neck cancer.
Epistemonikos ID: 4bf7efbb85f471c41ef46000c8b8755074106dc7
First added on: May 03, 2024